Does the nicotine metabolite ratio moderate smoking cessation treatment outcomes in real-world settings? A prospective study.

In a real-world setting, the nicotine metabolite ratio status of treatment-seeking smokers does not appear to contribute substantially to the differential effectiveness of varenicline and nicotine replacement therapy in Stop Smoking Services, when both pharmacotherapy and behavioural support are self-selected.